From: Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework
 | Eligibility | Recruitment | Setting | Organization | Delivery | Adherence | Follow Up | Outcomes | Analysis |
---|---|---|---|---|---|---|---|---|---|
Clinician investigator (n = 6) | 4.67 | 3.67 | 4.5 | 2.83 | 3.33 | 4.17 | 3.33 | 3.83 | 4.67 |
Non-clinician investigator (n = 6) | 4.50 | 4.33 | 4.33 | 3.08 | 3.17 | 4.83 | 3.75 | 3.50 | 4.67 |
Research staff (n = 6) | 4.00 | 3.75 | 4.50 | 2.75 | 3.42 | 4.33 | 3.75 | 4.00 | 4.46 |
Practice-interfacing staff (n = 3) | 4.33 | 3.33 | 5.00 | 3.00 | 3.67 | 4.00 | 3.67 | 3.67 | 4.67 |
Total investigators (n = 12) | 4.58 | 4.00 | 4.42 | 2.96 | 3.25 | 4.50 | 3.54 | 3.67 | 4.67 |
Total non-investigators (n = 9) | 4.17 | 3.54 | 4.75 | 2.86 | 3.54 | 4.17 | 3.71 | 3.83 | 4.56 |
TOTAL (n = 21) | 4.38 | 3.77 | 4.58 | 2.92 | 3.40 | 4.33 | 3.63 | 3.75 | 4.61 |